Cannabis is a safe and potentially safe form of chronic pain that afflicts people with sickle cell disease, according to a new clinical trial jointly led by researchers at the University of California, Irvine (UCI) and Dr. Donald Abrams of UC. It seems to be an effective treatment. San Francisco.
The results of this study, published July 17, 2020, show that opioids are currently the primary treatment for relieving the chronic and acute pain suffered by people suffering from sickle cell disease (SCD). point, it can have far-reaching implications.
SCD is a common inherited blood disorder, also known as SCD. Sickle cell anemia It is in a more serious stage. The disease affects an estimated 70,000 to 100,000 Americans.
The only treatment for SCD is bone marrow or stem cell transplantation. Disease Control Center (CDC).
Rise Opioid-related deaths and addictions It encourages doctors to prescribe them less often, which reduces treatment options for patients with sickle cell disease.
“These test results show that vaporized cannabis generally appears to be safe,” he said. Cannabis Research Center at the University of California, Irvine..
In addition to the immediate study, Gupta said the study opened the door for testing various forms of medical cannabis to treat chronic pain, including the vaporized forms used in the study. He pointed out that the number one reason people seek cannabis from the clinic is to treat pain.
“they [the trials] It also suggests that patients with sickle cell disease may be able to relieve pain with cannabis, and that cannabis may help society cope with opioid-related public health crises. Of course, larger studies with more participants are needed to better understand how cannabis can help people with chronic pain. “
The Double-blind, placebo-controlled, Randomized trials were the first trials to adopt such a gold standard method to assess the potential of cannabis to reduce pain in people with sickle cell disease. press release From UCI’s Cannabis Research Center.
Researchers assessed the level of pain in participants during treatment and found that the effectiveness of cannabis, which contains equal parts of THC and CBD, appears to increase over time.
As the five-day study period progressed, 23 subjects reported that pain had less and less effect on activities such as walking and sleep, and the amount of pain on mood was statistically significantly reduced. Did.
The survey results are JAMA network open..
var aepc_pixel = {"pixel_id":"546009932779707","user":{},"enable_advanced_events":"yes","fire_delay":"0"}, aepc_pixel_args = {}, aepc_extend_args = function( args ) { if ( typeof args === 'undefined' ) { args = {}; }
for(var key in aepc_pixel_args) args[key] = aepc_pixel_args[key];
return args; };
// Extend args if ( 'yes' === aepc_pixel.enable_advanced_events ) { aepc_pixel_args.language = navigator.language;
if ( document.referrer.indexOf( document.domain )
Warmington Backs Legalization In Debate Cinde Warmington, the Democratic challenger in New Hampshire's governor race, said during a debate last…
Two New Dispensaries Set To Open Two medical cannabis dispensaries are expected to open next week, bringing the total to…
Alcohol Lobbyists Encouraged Law Enforcement Officials To Push For Federal Hemp Crackdown, Report Says Politico reported Thursday that it obtained…
Federal Registrations Approved for Medical-Only States The Department of Justice announced on Friday that it has given federal registration and…
DEA Issues First Federal Dispensary Registrations The Trump administration has issued federal registrations to hundreds of medical marijuana dispensaries in…
New Bill Filed in the House Rep. Val Hoyle (D-OR) filed the Protecting American Hemp Farmers Act on Thursday. The…
